NASDAQ: VERV
Verve Therapeutics Inc Earnings Dates, Reports, Calls

Verve Therapeutics earnings were -$197.0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest VERV earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$50.1M, up 0.7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, VERV reported annual earnings of -$200.1M, with 27.1% growth.

VERV earnings history

Current Revenue
$24.4M
Current Earnings
-$197.0M
Current Profit Margin
-807.6%

VERV Return on Equity

Current Company
-35.2%
Current Industry
19.9%
Current Market
35%
VERV's Return on Equity (-35.2%)... subscribe to Premium to read more.
High Return on Equity Performance

VERV Return on Assets

Current Company
-27.7%
Current Industry
1.3%
VERV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VERV announces earnings.

VERV Return on Capital Employed

Current Company
-31.66%
Current Industry
14.3%
VERV's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VERV vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VERV-$183.03M-$197.03MN/A-$2.46
GHRS-$40.39M-$41.43MN/A-$0.79
IMNM-$303.58M-$305.35MN/A-$8.11
PLRX-$193.84M-$201.68MN/A-$3.34
SANA-$272.11M-$305.81MN/A-$1.40

Verve Therapeutics Earnings Reports & History FAQ

What were Verve Therapeutics's earnings last quarter?

On VERV's earnings call on Invalid Date, Verve Therapeutics (NASDAQ: VERV) reported Q3 2024 earnings per share (EPS) of -$0.59, up 18.06% year over year. Total VERV earnings for the quarter were -$50.13 million. In the same quarter last year, Verve Therapeutics's earnings per share (EPS) was -$0.72.

If you're new to stock investing, here's how to buy Verve Therapeutics stock.

Is Verve Therapeutics profitable or losing money?

As of the last Verve Therapeutics earnings report, Verve Therapeutics is currently losing money. Verve Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$197.03 million, a 2.19% increase year over year.

What was VERV's earnings growth in the past year?

As of Verve Therapeutics's earnings date in Invalid Date, Verve Therapeutics's earnings has grown year over year. VERV earnings in the past year totalled -$197.03 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.